Phase 2/3 human trials on the Oxford-AstraZeneca vaccine candidate by the Serum Institute of India (SII) were also underway in the country until last week, when they had to be paused after a trial participant in the UK developed an unexplained adverse reaction.
from Hindustan Times - india https://ift.tt/3mmvnEm
Subscribe to:
Post Comments
(
Atom
)
0 comments:
Post a Comment